Maze Therapeutics (MAZE) Tax Rate (2024 - 2025)
Maze Therapeutics (MAZE) reported Tax Rate of 79.65% for Q4 2025, up 11237.0% on a YoY basis from N/an in Q4 2024, and up 343.45% sequentially from 32.72% in Q4 2024.
Maze Therapeutics (MAZE) Tax Rate (2024 - 2025) Analysis & Trends
Maze Therapeutics (MAZE) has 2 years of Tax Rate data on file, last reported at 79.65% in Q4 2025.
- For the quarter ending Q4 2025, Tax Rate rose 11237.0% year-over-year to 79.65%; the trailing twelve-month figure through Dec 2025 stood at 13.55% (changed N/A YoY), and the FY2025 full-year result was 21.0%, changed 0.0% from the prior year.
- Tax Rate improved to 79.65% in Q4 2025, from 32.72% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 79.65% in Q4 2025 to a low of 32.72% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 79.65 |
| Dec 31, 2025 | 79.65 |
| Dec 31, 2025 | 79.65 |
| Dec 31, 2024 | -32.72 |
| Dec 31, 2024 | -32.72 |
| Dec 31, 2024 | -32.72 |
| Sep 30, 2024 | 1.20 |
| Sep 30, 2024 | 1.20 |
| Sep 30, 2024 | 1.20 |
| Jun 30, 2024 | 1.23 |
| Jun 30, 2024 | 1.23 |
| Jun 30, 2024 | 1.23 |